Abstract: Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.
Type:
Grant
Filed:
May 18, 2012
Date of Patent:
May 16, 2017
Assignee:
Momenta Pharmaceuticals, Inc.
Inventors:
Dorota A. Bulik, Carlos J. Bosques, Brian Edward Collins, Maurice Gaston Hains, Nathaniel J. Washburn, James Meador, Sean Smith, Naveen Bhatnagar
Abstract: The present invention relates to compositions and methods of engineered IgG Fc constructs, wherein said Fc constructs include one or more Fc domains.
Type:
Application
Filed:
April 28, 2016
Publication date:
March 9, 2017
Applicant:
Momenta Pharmaceuticals, Inc.
Inventors:
Carlos J. BOSQUES, James S. HUSTON, Jonathan C. LANSING, Leona E. LING, James MEADOR, III, Daniel ORTIZ, Laura RUTITZKY, Birgit C. SCHULTES
Abstract: A method for producing recombinant polypeptides, including antibodies, having targeted levels of carboxyl terminal (C-terminal) lysine or arginine residues is presented. The method involves culturing cells expressing said polypeptides in cell culture medium having sufficient levels of lysine, arginine, and/or agents that change intracellular pH. Culturing the cells under such conditions does not affect cell growth, cell viability, or titer.
Abstract: A multi-dimensional chromatographic method for the separation of N-glycans. The method comprises providing a glycan preparation that includes at least one negatively charged N-glycan. The glycan preparation is then separated by anion-exchange chromatography and at least one secondary chromatographic technique.
Type:
Grant
Filed:
November 8, 2013
Date of Patent:
September 20, 2016
Assignee:
Momenta Pharmaceuticals, Inc.
Inventors:
Ian Christopher Parsons, Ting Zheng, Nur Sibel Gunay, Carlos J. Bosques
Abstract: Pharmaceutical preparations containing polypeptides having particular sialylation patterns, and methods for the treatment of immune-related thrombocytopenia with such preparations, are described.
Type:
Application
Filed:
October 14, 2014
Publication date:
September 8, 2016
Applicant:
Momenta Pharmaceuticals Inc.
Inventors:
Birgit C. SCHULTES, Chia Lin CHU, Laura RUTITZKY, Lynn ZHANG, Leona E. LING
Abstract: Methods for analyzing, selecting, characterizing or classifying compositions of a co-polymer, e.g., glatiramer acetate are described. The methods entail analysis of pyro-glutamate in the composition, and, in some methods, comparing the amount of pyro-glutamate present in a composition to a reference standard.
Type:
Grant
Filed:
November 13, 2015
Date of Patent:
August 9, 2016
Assignee:
Momenta Pharmaceuticals, Inc.
Inventors:
Xiangping Zhu, Zachary Shriver, Yanjie Jiang, Corinne Bauer, James Eric Anderson, Peter James Ahern
Abstract: Methods for analyzing, selecting, characterizing or classifying compositions of a co-polymer, e.g., glatiramer acetate are described. The methods entail analysis of pyro-glutamate in the composition, and, in some methods, comparing the amount of pyro-glutamate present in a composition to a reference standard.
Type:
Grant
Filed:
July 9, 2015
Date of Patent:
July 19, 2016
Assignee:
Momenta Pharmaceuticals, Inc.
Inventors:
Xiangping Zhu, Zachary Shriver, Yanjie Jiang, Corinne Bauer, James Eric Anderson, Peter James Ahern
Abstract: Polysaccharide preparations lacking substantial anticoagulant activity are provided herein. Methods of making and using such preparations are provided.
Type:
Grant
Filed:
September 27, 2013
Date of Patent:
June 7, 2016
Assignee:
MOMENTA PHARMACEUTICALS, INC.
Inventors:
Mallikarjun Sundaram, Takashi Kei Kishimoto, Sucharita Roy
Abstract: Preparations of polysaccharides lacking substantial anticoagulant activity are provided herein. Methods of making and using such preparations are provided.
Type:
Grant
Filed:
November 3, 2008
Date of Patent:
May 31, 2016
Assignee:
MOMENTA PHARMACEUTICALS, INC.
Inventors:
Mallikarjun Sundaram, Takashi Kei Kishimoto, Sucharita Roy
Abstract: Described herein are pharmaceutical compositions comprising a LMWH preparation having at least one chain having a glycol split uronic acid residue (UG) in the preparation and uses thereof.
Type:
Application
Filed:
May 27, 2014
Publication date:
May 12, 2016
Applicant:
MOMENTA PHARMACEUTICALS, INC.
Inventors:
Kelly Neelon, Gary Mills, James Anderson
Abstract: The invention provides methods, databases and systems for making glycoprotein products having defined properties.
Type:
Application
Filed:
October 14, 2015
Publication date:
April 7, 2016
Applicant:
MOMENTA PHARMACEUTICALS, INC.
Inventors:
Brian Edward Collins, Carlos J. Bosques, Lakshmanan Thiruneelakantapillai, Dorota A. Bulik, Ian C. Parsons, Zachary Shriver, Rajeev Chillakuru, Ganesh Kaundinya
Abstract: The present disclosure provides, in part, methods for evaluating, identifying, and/or producing (e.g., manufacturing) a CTLA4-Fc fusion protein, e.g., abatacept. In some instances, methods herein allow highly resolved evaluation of abatacept useful for, inter alia, manufacturing abatacept, characterizing abatacept, identifying and/or confirming abatacept, monitoring the structure of abatacept, comparing abatacept preparations made over time or made under different conditions, and/or controlling the structure of abatacept.
Type:
Application
Filed:
May 31, 2013
Publication date:
December 24, 2015
Applicant:
Momenta Pharmaceuticals, Inc.
Inventors:
John ROBBLEE, Xiaomei HE, Yan YIN, Yin Yin LIN, Brian COLLINS, Jennifer MURPHY, Ganesh KAUNDINYA
Abstract: Polypeptide preparations having target levels of glycans, and methods of producing such polypeptide preparations using putrescine, are described.
Abstract: Polysaccharide preparations lacking substantial anticoagulant activity are provided herein. Methods of making and using such preparations are provided.
Type:
Grant
Filed:
September 27, 2013
Date of Patent:
December 15, 2015
Assignee:
MOMENTA PHARMACEUTICALS, INC.
Inventors:
Mallikarjun Sundaram, Takashi Kei Kishimoto, Sucharita Roy
Abstract: The present disclosure provides a method for determining the relative conformations of a protein provided in different protein preparations, comprising steps of: (i) obtaining a first 2D NOESY NMR spectrum of a first protein preparation; (ii) obtaining a second 2D NOESY NMR spectrum of a second protein preparation; and (iii); determining whether a protein has a different conformation in the first and second protein preparations by comparing one or more cross-peaks in the first 2D NOESY NMR spectrum with one or more corresponding cross-peaks in the second 2D NOESY NMR spectrum.
Type:
Grant
Filed:
April 15, 2008
Date of Patent:
November 10, 2015
Assignee:
Momenta Pharmaceuticals, Inc.
Inventors:
Ian Christopher Parsons, Jonathan Lansing, Carlos J. Bosques, Daniela Beccati
Abstract: The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.
Type:
Grant
Filed:
March 12, 2012
Date of Patent:
October 27, 2015
Assignee:
MOMENTA PHARMACEUTICALS, INC.
Inventors:
Nathaniel J. Washburn, Enrique Arevalo, Kevin Millea, Carlos J. Bosques, Jay Duffner, Brian E. Collins
Abstract: Described are oligosaccharides having a protecting group at two, a plurality, a majority of, or each position in the oligosaccharide which is amenable to derivatization. Collections, libraries and methods of making and using such oligosaccharides are also described.